#Health / Well-being #Diagnostics
- Endometriosis biomarkers
- Medical devices
- Personalized medicine
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Health / Well-being #Diagnostics
Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.
Endodiag is an innovative biotechnology company fully dedicated to the development of new solutions to improve the diagnosis of endometriosis.
Its management and founding team combines a strong industrial and entrepreneurship experience, over 20 years of pioneering research in the field of endometriosis, and an expertise in the IVD market.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Our first product, EndoGram®, is designed to improve and complement current endometriosis diagnostic practice based on laparoscopic surgery. It combines an innovative biopsy punch to simplify and standardize biopsy collection, a CE-marked sample collection kit and a proprietary method to analyse biological specimens.
EndoGram® provides gynaecologists with important information regarding each patient’s treatment susceptibility and disease aggressiveness.
Our second product EndoTech® & EndoSearch are still under development.
It’s a non-invasive IVD test that will help diagnose endometriosis from a simple blood sample. Based on endometriosis-specific circulating biomarkers it will completely revolutionize the diagnosis of this complex disease by making it easier, cheaper and much faster.
Finally, EndoTesting® is a unique pharmacotesting solution combining multiple assays (cell viability, proliferation, apoptosis, migration, cytotoxicity, invasion, etc.) and a large collection of cell lines and human biological samples.
It is designed to provide early expert information on the potential efficacy of drug candidates against endometriosis.
In same field
Research & development for an in vitro diagnostic tool for endometriosisDiscover
SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.Discover
Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.Discover
Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.Discover
Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.Discover
– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodiesDiscover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.Discover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell DiseaseDiscover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.Discover
AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.Discover